Registration now open for BOS Events 2025!

Dates for BOS Events 2025 are 11th and 12th June for BOS Basel 2025, and 25th and 26th November for BOS Manchester 2025. Please find further details outlining floor plans and pricing options at the event links provided.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2025)

RIC biologics

RIC is a privately-owned European center of excellence for analytical solutions and has been supporting industries and government agencies in various markets for over 35 years. Founded by Professor Pat Sandra in 1986 and currently led...
View profile

Featured Speaker (BOS Basel 2025)

In-house Manufacture or External Sourcing of Gene Editing Reagents to Support the Growing Cell and Gene Therapy Business

Dr firstname_2105 lastname_2105, Senior Program Lead, companyname_2105

ABSTRACT: Beyond small molecule drugs and classical biopharmaceuticals like antibodies, cell and gene therapies are becoming more and more important to treat patients with severe diseases. Genome editing holds a great promise for cell-based therapies. Reliable manufacture and supply of the reagents used for gene editing - in the necessary quality - is essential. Depending on the application, gene editing reagents (GERs) may be starting materials or drug substances to be made following GMP principles or under full GMP. For development, clinical and commercial manufacture, companies need to decide between... Click here to Read More